Literature DB >> 11517935

Cathepsin L, but not cathepsin B, is a potential kininogenase.

C Desmazes1, F Gauthier, G Lalmanach.   

Abstract

Although papain-like enzymes are strongly inhibited by their natural tight-binding inhibitors of the cystatin superfamily, cathepsins B and L may still retain some residual proteolytic activity toward Z-Phe-Arg-AMC in the presence of an excess of kininogen. This activity is abolished by adding E-64 or chicken cystatin. Cathepsins B and L show a single band of gelatinolytic activity when subjected to gelatin-SDS-PAGE. Adding high Mr kininogen, low Mr kininogen, T-kininogen, or chicken cystatin to cathepsin L results in additional intense bands of enzyme activity corresponding to the protease-inhibitor complexes. Cathepsin B does not produce these additional bands. This gelatinolytic activity was inhibited by E-64, but not by EDTA, PMSF or Pefabloc. Cathepsin L also specifically generated kinins from high and low molecular weight kininogens in vitro, but cathepsin B did not. T-kininogen did not release any immunoreactive kinins when complexed with cathepsin L, as previously observed using tissue kallikreins. The ability of cathepsin L to generate vasoactive peptides raises the question of the physiological significance of this mechanism during inflammation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11517935     DOI: 10.1515/BC.2001.098

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  7 in total

1.  Bauhinia bauhinioides cruzipain inhibitor reduces endothelial proliferation and induces an increase of the intracellular Ca2+ concentration.

Authors:  Mehmet Bilgin; Christiane Neuhof; Oliver Doerr; Utz Benscheid; Sheila S Andrade; Astrid Most; Yaser Abdallah; Mariana Parahuleva; Dursun Guenduez; Maria L Oliva; Ali Erdogan
Journal:  J Physiol Biochem       Date:  2010-08-02       Impact factor: 4.158

2.  Manipulating substrate and pH in zymography protocols selectively distinguishes cathepsins K, L, S, and V activity in cells and tissues.

Authors:  Catera L Wilder; Keon-Young Park; Philip M Keegan; Manu O Platt
Journal:  Arch Biochem Biophys       Date:  2011-09-29       Impact factor: 4.013

3.  Effect of plant neutrophil elastase inhibitor on leucocyte migration, adhesion and cytokine release in inflammatory conditions.

Authors:  C Oliveira; R A Navarro-Xavier; E A Anjos-Vallota; J O Martins; V L F Silveira; L R C Gonçalves; M S Araújo; G Motta; P Sannomiya; M L V Oliva
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

Review 4.  A comprehensive review on current understanding of bradykinin in COVID-19 and inflammatory diseases.

Authors:  Devasahayam Arokiar Balaya Rex; Neelanchal Vaid; K Deepak; Shobha Dagamajalu; T S Keshava Prasad
Journal:  Mol Biol Rep       Date:  2022-05-21       Impact factor: 2.742

Review 5.  Cathepsin K inhibitors for osteoporosis and potential off-target effects.

Authors:  Dieter Brömme; Fabien Lecaille
Journal:  Expert Opin Investig Drugs       Date:  2009-05       Impact factor: 6.206

6.  Cathepsin K: a cysteine protease with unique kinin-degrading properties.

Authors:  Emmanuel Godat; Fabien Lecaille; Claire Desmazes; Sophie Duchêne; Enrico Weidauer; Paul Saftig; Dieter Brömme; Christophe Vandier; Gilles Lalmanach
Journal:  Biochem J       Date:  2004-11-01       Impact factor: 3.857

Review 7.  Snake venom-derived bradykinin-potentiating peptides: A promising therapy for COVID-19?

Authors:  Ahmed S Gouda; Bruno Mégarbane
Journal:  Drug Dev Res       Date:  2020-08-05       Impact factor: 5.004

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.